Endo pays $658M in a further bet on collagen-based medicines, buying out longtime biopharma partner
							
								A little less than two years after Endo Pharmaceuticals’ deal to purchase Somerset Therapeutics fell through, the Irish drugmaker is returning to the well with a much bigger acquisition.